Labetalol

Generic Name
Labetalol
Brand Names
Trandate
Drug Type
Small Molecule
Chemical Formula
C19H24N2O3
CAS Number
36894-69-6
Unique Ingredient Identifier
R5H8897N95
Background

Labetalol is a racemic mixture of 2 diastereoisomers where dilevalol, the R,R' stereoisomer, makes up 25% of the mixture. Labetalol is formulated as an injection or tablets to treat hypertension.

Labetalol was granted FDA approval on 1 August 1984.

Indication

Labetalol injections are indicated to control blood pressure in severe hypertension. Labetalol tablets are indicated alone or in combination with antihypertensives like thiazides and loop diuretics to manage hypertension.

Associated Conditions
Chronic Stable Angina Pectoris, Hypertension, Hypertensive Emergency, Hypertensive crisis, Pheochromocytoma, Subarachnoid Hemorrhage
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath